According to a report from Globe Newswire on January 13th, the U.S. Food and Drug Administration's (FDA) proposal to reduce the nicotine content in cigarettes has been approved by the Office of Management and Budget (OMB) on January 3rd, 2025. An FDA spokesperson stated that this policy may be one of the most impactful population-level actions in the history of U.S. tobacco product regulation.
The proposal aims to significantly reduce the nicotine content in cigarettes. 22nd Century Group, Inc., a US tobacco company, announced its support for the proposal and is prepared to provide necessary support. The company claims that its VLN brand of low-nicotine cigarettes aligns well with the proposal.
Larry Firestone, CEO of 22nd Century Group, Inc., stated that...
The approval of OMB marks an important step forward for this policy. We look forward to the federal government taking further concrete actions to make this science-supported, non-partisan policy to reduce smoking harm a reality.
Since 2009, 22nd Century Group, Inc. has been conducting and developing various federally funded clinical studies to advance this policy. The company became the first to receive FDA authorization to launch low-nicotine cigarettes aimed at reducing smoking harm by introducing VLN low-nicotine cigarettes. Currently, the company is working on launching more low-nicotine products while promoting low-nicotine cigarettes as a standalone category in the market.
According to reports, 22nd Century Group, Inc. is a tobacco company based in the United States that specializes in the sales and distribution of its own patented new low-nicotine tobacco products. The company claims that the nicotine content of its flagship product, VLN cigarettes, is 95% lower than traditional cigarettes.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
